skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: DOAJ Directory of Open Access Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview
Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview
Material Type:
Artigo 		Adicionar ao Meu Espaço

Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview

Kciuk, Mateusz ; Marciniak, Beata ; Kontek, Renata

International journal of molecular sciences, 2020-07, Vol.21 (14), p.4919 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
2
A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer
A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

A multicenter retrospective observational NAPOLEON2 study of nanoliposomal irinotecan with fluorouracil and folinic acid in patients with unresectable pancreatic cancer

Kodama, Tomoko ; Imajima, Takashi ; Shimokawa, Mototsugu ; Otsuka, Taiga ; Kawahira, Masahiro ; Nakazawa, Junichi ; Hori, Takeshi ; Shibuki, Taro ; Arima, Shiho ; Ido, Akio ; Miwa, Keisuke ; Okabe, Yoshinobu ; Koga, Futa ; Ueda, Yujiro ; Kubotsu, Yoshihito ; Shimokawa, Hozumi ; Takeshita, Shigeyuki ; Nishikawa, Kazuo ; Komori, Azusa ; Otsu, Satoshi ; Hosokawa, Ayumu ; Sakai, Tatsunori ; Sakai, Kenji ; Oda, Hisanobu ; Kawahira, Machiko ; Arita, Shuji ; Honda, Takuya ; Taguchi, Hiroki ; Tsuneyoshi, Kengo ; Kawaguchi, Yasunori ; Fujita, Toshihiro ; Sakae, Takahiro ; Shirakawa, Tsuyoshi ; Mizuta, Toshihiko ; Mitsugi, Kenji

Scientific reports, 2024-05, Vol.14 (1), p.12422-10, Article 12422 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Blood-brain barrier disruption and delivery of irinotecan in a rat model using a clinical transcranial MRI-guided focused ultrasound system
Blood-brain barrier disruption and delivery of irinotecan in a rat model using a clinical transcranial MRI-guided focused ultrasound system
Material Type:
Artigo 		Adicionar ao Meu Espaço

Blood-brain barrier disruption and delivery of irinotecan in a rat model using a clinical transcranial MRI-guided focused ultrasound system

McDannold, Nathan ; Zhang, Yongzhi ; Supko, Jeffrey G ; Power, Chanikarn ; Sun, Tao ; Vykhodtseva, Natalia ; Golby, Alexandra J ; Reardon, David A

Scientific reports, 2020-05, Vol.10 (1), p.8766-19, Article 8766 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters
Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters

Oyaga-Iriarte, Esther ; Insausti, Asier ; Sayar, Onintza ; Aldaz, Azucena

Journal of pharmacological sciences, 2019-05, Vol.140 (1), p.20-25 [Periódico revisado por pares]

Japan: Elsevier B.V

Texto completo disponível

Citações Citado por
5
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience

Glassman, Danielle C ; Palmaira, Randze L ; Covington, Christina M ; Desai, Avni M ; Ku, Geoffrey Y ; Li, Jia ; Harding, James J ; Varghese, Anna M ; O'Reilly, Eileen M ; Yu, Kenneth H

BMC cancer, 2018-06, Vol.18 (1), p.693-693, Article 693 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
6
Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study
Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study

Park, Se Jun ; Kim, Hyunho ; Shin, Kabsoo ; Hong, Tae Ho ; Suh, Ja Hee ; Lee, Myung Ah

BMC cancer, 2021-11, Vol.21 (1), p.1176-1176, Article 1176 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
7
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI‐1 study

Bang, Yung‐Jue ; Li, Chung‐Pin ; Lee, Kyung‐Hun ; Chiu, Chang‐Fang ; Park, Joon Oh ; Shan, Yan‐Shen ; Kim, Jun Suk ; Chen, Jen‐Shi ; Shim, Hyun‐Jeong ; Rau, Kun‐Ming ; Choi, Hye Jin ; Oh, Do‐Youn ; Belanger, Bruce ; Chen, Li‐Tzong

Cancer science, 2020-02, Vol.111 (2), p.513-527 [Periódico revisado por pares]

England: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
8
Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study

Perkhofer, L ; Berger, A W ; Beutel, A K ; Gallmeier, E ; Angermeier, S ; Fischer von Weikersthal, L ; Goetze, T O ; Muche, R ; Seufferlein, T ; Ettrich, T J

BMC cancer, 2019-10, Vol.19 (1), p.990-990, Article 990 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
9
pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment
pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment

Nunes, Shirleide Santos ; Miranda, Sued Eustaquio Mendes ; de Oliveira Silva, Juliana ; Fernandes, Renata Salgado ; de Alcântara Lemos, Janaína ; de Aguiar Ferreira, Carolina ; Townsend, Danyelle M. ; Cassali, Geovanni Dantas ; Oliveira, Mônica Cristina ; Branco de Barros, André Luís

Biomedicine & pharmacotherapy, 2021-12, Vol.144, p.112317-112317, Article 112317 [Periódico revisado por pares]

France: Elsevier Masson SAS

Texto completo disponível

Citações Citado por
10
Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort
Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort
Material Type:
Artigo 		Adicionar ao Meu Espaço

Author Correction: The Impact of Liposomal Irinotecan on the Treatment of Advanced Pancreatic Adenocarcinoma: Real-World Experience in a Taiwanese Cohort

Su, Yung-Yeh ; Chiang, Nai-Jung ; Tsai, Hui-Jen ; Yen, Chia-Jui ; Shan, Yan‐Shen ; Chen, Li‐Tzong

Scientific reports, 2020-11, Vol.10 (1), p.20199-20199, Article 20199 [Periódico revisado por pares]

London: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (1.414)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (1.439)
  2. Anais de Congresso  (1)
  3. magazinearticle  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1998  (24)
  2. 1998Até2003  (29)
  3. 2004Até2009  (85)
  4. 2010Até2016  (287)
  5. Após 2016  (1.017)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (1.413)
  2. Japonês  (153)
  3. Russo  (16)
  4. Coreano  (12)
  5. Chinês  (12)
  6. Português  (5)
  7. Espanhol  (3)
  8. Persa  (1)
  9. Croatian  (1)
  10. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.